SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-025388
Filing Date
2023-07-24
Accepted
2023-07-24 06:20:54
Documents
14
Period of Report
2023-07-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230724.htm   iXBRL 8-K 29608
2 EX-99.1 exhibit991-8xk.htm EX-99.1 792056
  Complete submission text file 0001628280-23-025388.txt   1044198

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230724.xsd EX-101.SCH 3364
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230724_def.xml EX-101.DEF 18365
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230724_lab.xml EX-101.LAB 36196
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230724_pre.xml EX-101.PRE 18807
8 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230724_htm.xml XML 6236
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 231103682
SIC: 2834 Pharmaceutical Preparations